-
FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine
americanpharmaceuticalreview
March 04, 2021
The U.S. Food and Drug Administration (FDA) announced it is allowing undiluted frozen vials of the Pfizer-BioNTech COVID-19 Vaccine to be transported and stored at conventional temperatures commonly found in pharmaceutical freezers for a period of up ...
-
Pfizer gets full US FDA nod for LORBRENA as first-line treatment for ALK-Positive metastatic NSCLC
expresspharma
March 04, 2021
Approval is based on CROWN trial, which showed a 72 per cent reduction in risk of progression or death for treatment with LORBRENA vs. XALKORI.
-
Pfizer, Oxford vaccine reduce infection risk in elderly
expresspharma
March 03, 2021
Evidence for the Pfizer vaccine suggests that it leads to 83 per cent reduction in deaths from COVID-19.
-
Pfizer’s tick-borne encephalitis vaccine gets US priority review
pharmatimes
February 26, 2021
The US Food and Drug Administration (FDA) has accepted for priority review Pfizer’s tick-borne encephalitis (TBE) vaccine to prevent TBE in children and adults aged one year or older.
-
Pfizer Partners with Medicines Manufacturing Innovation Center
contractpharma
February 26, 2021
CPI has formed an agreement with Pfizer, making it the newest partner of the Medicines Manufacturing Innovation Center collaboration.
-
Pfizer Selects Seven Bridges to Support RNA Sequencing Data
contractpharma
February 25, 2021
Seven Bridges will centralize and manage terabytes scRNASeq data, which provides detailed analysis of gene expression in individual cells.
-
Pfizer, BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature
americanpharmaceuticalreview
February 24, 2021
Pfizer and BioNTech announced the submission of new data to the U.S. Food and Drug Administration (FDA) demonstrating the stability of their COVID-19 vaccine when stored at -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in ...
-
Pfizer accused of ‘bullying’ Latin American countries during vaccine negotiations
pharmaceutical-technology
February 24, 2021
Latin American countries have accused Pfizer of ‘high-level bullying’ during Covid-19 vaccine negotiations, according to a report by the Bureau of Investigative Journalism published in partnership with STAT.
-
UK to provide COVID-19 vaccine to all adults July-end
expresspharma
February 22, 2021
All adults in Britain will be offered the first shot of a COVID-19 vaccine by the end of July, Prime Minister Boris Johnson said.
-
Pfizer, BioNTech to Supply EU with 200 Million Additional Doses of COMIRNATY
americanpharmaceuticalreview
February 20, 2021
Pfizer and BioNTech announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’ COVID-19 vaccine, to the 27 European Union (EU) member states.